Urinary adiponectin excretion is increased in patients with overt diabetic nephropathy

Biochemical and Biophysical Research Communications

Volumn 316, Issue 1, 2004, Pages 165-169

  Koshimura, Jun ^a   Fujita, Hiroki ^a   Narita, Takuma ^a   Shimotomai, Takashi ^a   Hosoba, Mihoko ^a   Yoshioka, Naomi ^a   Kakei, Masafumi ^a   Fujishima, Hiromi ^a   Ito, Seiki ^a  

^a AKITA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Diabetic nephropathy; Radioimmunoassay; Serum adiponectin level; Type 2 diabetes; Urinary adiponectin excretion; Western blot analysis

Indexed keywords

ADIPONECTIN;

ADULT; AGED; ARTICLE; BLOOD VESSEL INJURY; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETIC NEPHROPATHY; EVALUATION; FILTRATION; HUMAN; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN SYNTHESIS; URINARY EXCRETION; WESTERN BLOTTING;

ADIPONECTIN; ALBUMINURIA; DIABETES MELLITUS, TYPE 2; DIABETIC NEPHROPATHIES; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MALE; MIDDLE AGED; PROTEINS;

EID: 1542345756     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbrc.2004.02.032     Document Type: Article

References (17)

1. Maeda K., Okubo K., Shimomura I., Funahashi T., Matsuzawa Y., Matsubara K. cDNA cloning and expression of a novel adipose specific collagen-like factor, apM1 (adipose most abundant gene transcript 1). Biochem. Biophys. Res. Commun. 221:1996;286-289.
2. Scherer P.E., Williams S., Fogliano M.F., Baldini G., Lodish H.F. A novel serum protein similar to C1q, produced exclusively in adipocytes. J. Biol. Chem. 270:1995;26746-26749.
3. Hu E., Liang P., Spiegelman B.M. AdipoQ is a novel adipose-specific gene dysregulated in obesity. J. Biol. Chem. 271:1996;10697-10703.
4. Nakano Y., Tobe T., Choi-Miura N.H., Mazada T., Tomita M. Isolation and characterization of GBP28, a novel gelatin-binding protein purified from human plasma. J. Biochem. 120:1996;803-812.
5. Arita Y., Kihara S., Ouchi N., Takahashi M., Maeda K., Miyagawa J., Hotta K., Shimomura I., Nakamura T., Miyaoka K. Paradoxical decrease of an adipocyte-specific protein, adiponectin, in obesity. Biochem. Biophys. Res. Commun. 257:1999;79-83.
6. Hotta K., Funahashi T., Aritsa Y., Takahashi M., Matsuda M., Okamoto Y., Iwahashi H., Kuriyama H., Ouchi N., Maeda K., Nishida M., Kihara S., Sakai N., Nakajima T., Hasegawa K., Miraguchi M., Ohmoto Y., Nakamura T., Yamashita S., Hanafusa T., Matsuzawa Y. Plasma concentration of a novel adipose-specific protein, adiponectin, in type 2 diabetic patients. Arterioscler. Thromb. Vasc. Biol. 20:2000;1595-1599.
7. Weyer C., Funahashi T., Tanaka S., Hotta K., Matsuzawa Y., Pratley R.E., Tataranii P.A. Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia. J. Clin. Endocrinol. Metab. 2001;1930-1935.
8. Lindsay R., Funahashi T., Hanson R., Matsuzawa Y., Tanaka S., Tataranii A., Knowler W., Krakoff J. Adiponectin and development of type 2 diabetes in the Pima Indian population. Lancet. 360:2002;57-58.
9. Yamauchi T., Kamon J., Waki H., Terauchi Y., Kubota N., Hara K., Mori Y., Ide T., Murakami K., Tsuboyama-Kasaoka N., Ezaki O., Akanuma Y., Gavrilova O., Vinson C., Reitman M.L., Kagechika H., Shudo K., Yoda M., Nakano Y., Tobe K., Nagai R., Kimura S., Tomita M., Froguel P., Kadowaki T. The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity. Nat. Med. 7:2001;941-946.
10. Berg A.H., Combs T.P., Du X., Brownlee M., Scherer P.E. The adipocyte-secreted protein Acrp30 enhances hepatic insulin action. Nat. Med. 7:2001;947-953.
11. Zoccali C., Mallamaci F., Tripepi G., Benedetto F.A., Cutrupi S., Parlongo S., Malatino L.S., Bonanno G., Seminara G., Rapisarda F., Fatuzzo P., Buemi M., Nicocia G., Tanaka S., Ouchi N., Kihara S., Funahashi T., Matsuzawa Y. Adiponectin, metabolic risk factors, and cardiovascular events among patients with end-stage renal disease. J. Am. Soc. Nephrol. 13:2002;134-141.
12. Zoccali C., Mallamaci F., Panuccio V., Tripepi G., Cutrupi S., Parlongo S., Catalano F., Tanaka S., Ouchi N., Kihara S., Funahashi T., Matsuzawa Y. Adiponectin is markedly increased in patients with nephrotic syndrome and is related to metabolic risk factors. Kidney Int. 84(Suppl.):2003;S98-S102.
13. Yang W.S., Jeng C.Y., Wu T.J., Tanaka S., Funahashi T., Matsuzawa Y., Wang J.P., Chen C.L., Tai T.Y., Chuang L.M. Synthetic peroxisome proliferator-activated receptor-γ agonist, rosiglitazone, increases plasma levels of adiponectin in type 2 diabetic patients. Diabetes Care. 25:2002;376-380.
14. Hirose H., Kawai T., Yamamoto Y., Taniyama M., Tomita M., Matsubara K., Okazaki Y., Ishii T., Oguma Y., Takei I., Saruta T. Effects of pioglitazone on metabolic parameters, body fat distribution, and serum adiponectin levels in Japanese male patients with type 2 diabetes. Metabolism. 2002;314-317.
15. Phillips S.A., Ciaraldi T.P., Kong A.P.S., Bandukwala R., Aroda V., Carter L., Baxi S., Mudaliar S.R., Henry R.R. Modulation of circulating and adipose tissue adiponectin levels by antidiabetic therapy. Diabetes. 52:2003;667-674.
16. Brodows R.G., Nichols D., Shaker G., Kubasik N.P. Evaluation of a new radioimmunoassay for urinary albumin. Diabetes Care. 9:1986;189-193.
17. Ouchi N., Kihara S., Arita Y., Maeda K., Kuriyama H., Okamoto Y., Hotta K., Nishida M., Takahashi M., Nakamura T., Yamashita S., Funahashi T., Matsuzawa Y. Novel modulator for endothelial adhesion molecules: adipocyte-derived plasma protein adiponectin. Circulation. 100:1999;2473-2476.